Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G William MacEwan

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of Evaluation in Clinical Practice|January 21, 2006
Evaluation of a community mental health carepath for early psychosisLaura A Hanson, Martha Grypma, Karen A Tee, et al.
Schizophrenia Research|February 26, 2008
Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosisTania Lecomte, Alicia Spidel, Claude Leclerc, et al.
The Journal of Clinical Psychiatry|July 8, 2011
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorderWilliam G Honer, G William MacEwan, Alain Gendron, et al.
Journal of Psychiatry & Neuroscience : JPN|December 2, 2009
A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyWilliam G Honer, Ric M Procyshyn, Eric Y H Chen, et al.
Journal of Psychiatry & Neuroscience : JPN|September 5, 2006
The need for speed: an update on methamphetamine addictionAlasdair M Barr, William J Panenka, G William MacEwan, et al.
Drug and Alcohol Dependence|January 1, 2013
Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findingsWilliam J Panenka, Ric M Procyshyn, Tania Lecomte, et al.
Schizophrenia Research|July 9, 2013
Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patientsVina M Goghari, Geoffrey N Smith, William G Honer, et al.
CNS Drugs|August 19, 2007
Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophreniaWilliam G Honer, Allen E Thornton, Megan Sherwood, et al.
Psychiatric Services (Washington, D.C.)|April 5, 2011
The assessment of symptom severity and functional impairment with DSM-IV axis VGeoffrey Norman Smith, Thomas S Ehmann, Sean W Flynn, et al.
Journal of the International Neuropsychological Society : JINS|April 5, 2012
Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosisHeather A Baitz, Allen E Thornton, Ric M Procyshyn, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of Evaluation in Clinical Practice|January 21, 2006
Evaluation of a community mental health carepath for early psychosisLaura A Hanson, Martha Grypma, Karen A Tee, et al.
Schizophrenia Research|February 26, 2008
Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosisTania Lecomte, Alicia Spidel, Claude Leclerc, et al.
The Journal of Clinical Psychiatry|July 8, 2011
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorderWilliam G Honer, G William MacEwan, Alain Gendron, et al.
Journal of Psychiatry & Neuroscience : JPN|December 2, 2009
A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyWilliam G Honer, Ric M Procyshyn, Eric Y H Chen, et al.
Journal of Psychiatry & Neuroscience : JPN|September 5, 2006
The need for speed: an update on methamphetamine addictionAlasdair M Barr, William J Panenka, G William MacEwan, et al.
Drug and Alcohol Dependence|January 1, 2013
Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findingsWilliam J Panenka, Ric M Procyshyn, Tania Lecomte, et al.
Schizophrenia Research|July 9, 2013
Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patientsVina M Goghari, Geoffrey N Smith, William G Honer, et al.
CNS Drugs|August 19, 2007
Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophreniaWilliam G Honer, Allen E Thornton, Megan Sherwood, et al.
Psychiatric Services (Washington, D.C.)|April 5, 2011
The assessment of symptom severity and functional impairment with DSM-IV axis VGeoffrey Norman Smith, Thomas S Ehmann, Sean W Flynn, et al.
Journal of the International Neuropsychological Society : JINS|April 5, 2012
Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosisHeather A Baitz, Allen E Thornton, Ric M Procyshyn, et al.
Pageof 5